[1]
|
S. Ozsu, F. Oztuna, Y. Bulbul, et al. “The Role of Risk Factors in Delayed Diagnosis of Pulmonary Embolism,” American Journal of Emergency Medicine, Vol. 29, No. 1, 2011, pp. 26-32.
http://dx.doi.org/10.1016/j.ajem.2009.07.005
|
[2]
|
V. F. Tapson, “Acute Pulmonary Embolism,” The New England Journal of Medicine, Vol. 358, No. 10, 2008, pp. 1037-1052. http://dx.doi.org/10.1056/NEJMra072753
|
[3]
|
D. C. Gaze, “Ischemia Modified Albumin: A Novel Biomarker for the Detection of Cardiac Ischemia,” Drug Metabolism and Pharmacokinetics, Vol. 24, No. 4, 2009, pp. 333-341. http://dx.doi.org/10.2133/dmpk.24.333
|
[4]
|
B. S. Hausen, C. Signor, H. Kober, E. Tatsch, R. S. Pereira, T. Duarte, C. L. Hermes, M. M. Duarte and R. N. Moresco, “Effect of Temperature on Albumin Cobalt Binding and Its Influence on Ischemia-Modified Albumin Levels in Patients with Suspected Acute Coronary Syndrome,” Clinical Laboratory, Vol. 58, No. 1-2, 2012, pp. 169-172.
|
[5]
|
K. Han, N. Jia, L. Yang and L. Q. Min, “Correlation between Ischemia-Modified Albumin and Lipid Levels in Patients with Acute Cerebrovascular Disease,” Molecular Medicine Reports, Vol. 6, No. 3, 2012, pp. 621-624.
|
[6]
|
M. Uygun, S. Yilmaz, M. Pekdemir, C. Duman and Y. S. Gürbüz, “The Diagnostic Value of Ischemia-Modified Albumin in a Rat Model of Acute Mesenteric Ischemia,” Academic Emergency Medicine, Vol. 18, No. 4, 2011, pp. 355-359.
http://dx.doi.org/10.1111/j.1553-2712.2011.01045.x
|
[7]
|
K. Maneewong, T. Mekrungruang-wong, S. Luangaram, T. Thongsri and S. Kumphune, “Combinatorial Determination of Ischemia Modified Albumin and Protein Carbonyl in the Diagnosis of NonST-Elevation Myocardial Infarction,” Indian Journal of Clinical Biochemistry, Vol. 26, No. 4, 2011, pp. 389-395.
http://dx.doi.org/10.1007/s12291-011-0118-2
|
[8]
|
E. Kountana, K. Tziomalos, P. Semertzidis, F. Dogrammatzi, A. Slavakis, S. Douma, C. Zamboulis and P. Geleris, “Comparison of the Diagnostic Accuracy of Ischemia-Modified Albumin and Echocardiography in Patients with Acute Chest Pain,” Experimental & Clinical Cardiology, Vol. 18, No. 2, 2013, pp. 98-100.
|
[9]
|
A. Toker, A. Aribas, F. H. Yerlikaya, E. Tasyurek and K. Akbuga, “Serum and Saliva Levels of Ischemia-Modified Albumin in Patients with Acute Myocardial Infarction,” Journal of Clinical Laboratory Analysis, Vol. 27, No. 2, 2013, pp. 99-104. http://dx.doi.org/10.1002/jcla.21569
|
[10]
|
W. Ghanima, M. Abdelnoor, M. C. Mowinckel and P. M. Sandset, “The Performance of STA-Liatest D-Dimer Assay in Out-Patients with Suspected Pulmonary Embolism,” British Journal of Haematology, Vol. 132, No. 2, 2006, pp. 210-215.
http://dx.doi.org/10.1111/j.1365-2141.2005.05859.x
|
[11]
|
D. Bar-Or, E. Lau and J. Winker, “A Novel Assay for Cobalt-Albumin Binding and It’s Potential as a Marker Formyocardial Ischemia—A Preliminary Report,” The Journal of Emergency Medicine, Vol. 19, No. 4, 2000, pp. 311-315.
http://dx.doi.org/10.1016/S0736-4679(00)00255-9
|
[12]
|
A. van Belle, H. R. Buller, M. V. Huisman, P. M. Huisman, K. Kaasjager, P. W. Kamphuisen, M. H. Kramer, M. J. Kruip, J. M. Kwakkel-van Erp, F. W. Leebeek, M. Nijkeuter, M. H. Prins, M. Sohne and L. W. Tick, “Effectiveness of Managing Suspected Pulmonary Embolism Using an Algorithm Combining Clinical Probability, D-Dimer Testing, and Computed Tomography,” JAMA, Vol. 295, No. 2, 2006, pp. 172-179.
http://dx.doi.org/10.1001/jama.295.2.172
|
[13]
|
V. King, A. A. Vaze, C. S. Moskowitz, L. J. Smith and M. S. Ginsberg, “D-Dimer Assay to Exclude Pulmonary Embolism in High Risk Oncologic Population: Correlation with CT Pulmonaryangiography in an Urgent Care Setting,” Radiology, Vol. 247, No. 3, 2008, pp. 854-861.
http://dx.doi.org/10.1148/radiol.2473070939
|
[14]
|
T. Walter, P. Apfaltrer, F. Weilbacher, M. Meyer, S. O. Schoenberg, C. Fink and J. Gruettner, “Predictive Value of High-Sensitivity Troponin I and D-Dimer Assays for Adverse Outcome in Patients with Acute Pulmonary Embolism,” Experimental and Therapeutic Medicine, Vol. 5, No. 2, 2013, pp. 586-590.
|
[15]
|
S. F. Alnomasy, S. Ansari, M. A. Izhari, S. Alam and S. Ali, “Evaluation of D-Dimer Level among Adult Patients in Al-Quwayyah Government Hospital, Saudi Arabia,” Journal of Applied Pharmaceutical Science, Vol. 2, No. 12, 2012, pp. 82-84.
|
[16]
|
S. Turedi, A. Gunduz, A. Mentese, M. Topbas, S. C. Karahan, S. Yeniocak, I. Turan, O. Eroglu, U. Ucar, Y. Karaca, S. Turkmen and R. M. Russell, “The value of Ischemia-Modified Albumin Compared with D-Dimer in the Diagnosis of Pulmonary Embolism,” Respiratory Research, Vol. 30, No. 9, 2008, p. 49.
http://dx.doi.org/10.1186/1465-9921-9-49
|
[17]
|
G. Waser, S. Kathriner and W. A. Wuillemin, “Performance of the Automated and Rapid STA Liatest D-Dimer on the STA-R Analyzer,” Thrombosis Research, Vol. 116, No. 2, 2005, pp. 165-170.
http://dx.doi.org/10.1016/j.thromres.2004.12.003
|
[18]
|
S. Turedi, A. Gunduz, A. Mentese, S. C. Karahan, S. E. Yilmaz, O. Eroglu, I. Nuhoglu, I. Turan and M. Topbas, “The Value of Ischemia-Modified Albumin in the Diagnosis of Pulmonary Embolism,” American Journal of Emergency Medicine, Vol. 25, No. 7, 2007, pp. 770-773.
http://dx.doi.org/10.1016/j.ajem.2006.12.013
|
[19]
|
L. B. Zheng, Z. Q. Wang, Z. Wang, M. Peng, J. T. Zhang, Z. He and L. G. Shi, “The Application of Ischemia Modified Albumin in the Diagnosis of Acute Pulmonary Embolism,” Journal of Clinical Cardiology, Vol. 9, No. 1, 2010, pp. 100-105.
|
[20]
|
K. Hogg, E. Hinchliffe, S. Halsam, A. Valkov and F. Lecky, “Is Ischaemia-Modified Albumin a Test for Venous Thromboembolism?” Emergency Medicine Journal, Vol. 29, No. 6, 2012, pp. 455-459.
|